Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 11, 2001
Issued Date -
N/A
app pub date -
Dec 16, 1997
filing date -
May 25, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Oligodeoxyribonucleotides in which at least two 2'-deoxy-.beta.-D-erythro-pentofuranosyl groups are replaced by 2'-deoxy-.beta.-D-threo-pentofuranosyl groups at both the 5' end and 3' end, and oligodeoxyribonucleotides in which at least 20% of the 2'-deoxy-.beta.-D-erythro-pentofuranosyl groups in consecutive nucleotide building blocks are replaced by 2'-deoxy-.beta.-D-threo-pentofuranosyl groups and which are composed of 6 to 100 nucleotide building blocks, are suitable for the inhibition of the expression of viral genes and oncogenes by the antisense principle and can be used for the production of pharmaceutical agents with antiviral activity.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully